Molecular Detection of Brucella spp. by real-time PCR

<<Return to Laboratory

Accredited by the Standards Council of Canada to Laboratory no. 594 - CAN-P-4E (ISO/IEC 17025)

Requisition Forms

Reference Details

Description:

Molecular detection by real-time PCR of Brucella spp.

Test Category:
Molecular Detection
Pathogen:
Brucella spp.
Illnesses and Diseases:
  • Brucellosis
Specimen:

Pure bacterial culture, whole blood – minimum 0.5 mL, cerebrospinal fluid (CSF) – minimum 0.5 mL, biopsy tissue, powder

Collection Method:

Pure bacterial culture – plate or swab; Whole blood – EDTA tube; Tissue or CSF – submit in a sterile collection tube; powder – submit in a sterile 2 mL o-ring microcentrifuge tube.

Specimen Processing, Storage and Shipping:

Store blood samples refrigerated until shipped for testing. Store tissue samples and CSF frozen until shipped for testing. Store bacterial cultures refrigerated until shipped for testing.

Transportation of Dangerous Goods:

Shipping of specimens shall be done by a TDG certified individual in accordance with TDG regulations. For additional information regarding classification of specimens for the purposes of shipping, consult either Part 2 Appendix 3 of the TDG Regulations or section 3.6.2 of the IATA Dangerous Goods Regulations as applicable.

For additional guidance on the transport of infectious substances in other languages, please click on the link below.

http://www.who.int/ihr/capacity-strengthening/infectious-substances/en/

Patient Criteria:

Suspected Brucella spp. infection.

Accompanying Documentation:

Completed Bioforensics Assay Development and Diagnostics requisition including sender name, address and telephone number. Patient name or identifier (referring lab #), date of birth, suspected exposure, test(s) requested, clinical history. Type of specimen and date collected. If possible, include the antibiotics administered and travel history.

Comments:

N/A

Methods and Interpretation of Results:

Real-time PCR is performed using three assays – one specific for Brucella spp., one specific for Brucella abortus, and the third specific for Brucella melitensis.

Confirmatory tests of a sample positive for Brucella spp. by real-time PCR result may include urease test, susceptibility to Brucella phage Tbilisi, gel formation (Brucella canis), Single Nucleotide Polymorphisms (SNPs), Multiple Locus Variable Tandem Repeat Analysis (MLVA), and Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry (MALDI-TOF MS) bacterial analysis.

MALDI-TOF MS will be performed on all samples negative for Brucella by real-time PCR, as long as the sample provides bacterial growth by culture.

Turnaround Time:

4 calendar days for a preliminary result; 14 calendar days for a final result for standard sample type; 35 calendar days for a final result for any non-standard specimen type, specialized testing requests or  clinical samples such as blood or tissue requiring a 28 day incubation period.

Contact:
Phone: (204) 784-5928 or 1-877-212-6108
Fax: (204) 789-5009
References:
  1. Ferreira, L., Castano, S.V., Sanchez-Juanes, F., Gonzales-Cabero, S., Menegotto, F., Orduna-Domingo, A., Gonzales-Buitrago, J.M., Munoz-Bellido, J.L., 2010.  Identification of Brucella by MALDI-TOF mass spectrometry.  Fast and reliable identification from agar plates and blood cultures.  PLOS One 5, e14235.
  2. Tracz, D.M., McCorrister, S.J., Westmacott, G.R., Corbett, C.R., 2012.  Effect of gamma radiation on the identification of bacterial pathogens by MALDI-TOF MS. J. Microbiol. Methods 92, 132-134.
Related Information: